MDAS 19.41 Medassets Inc $MDAS Hit a 52 week low of 19.33

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
MDAS 19.41 Medassets Inc $MDAS Hit a 52 week low of 19.33 Closing the day 10:44 at 19.41 -0.33 -1.67% With a day low of 19.33 and a total volume of 50,269.

MDAS Recent Posts: http://investorshangout.com/MedAssets-Inc-MDAS-54720/

MDAS Medassets Inc Recent Headline News

MedAssets Earnings Hindsight: Down 11.0% in Last 19 Days (MDAS)
Comtex SmarTrend(R) - Mon Nov 17, 3:32PM CST
19 days ago, on October 29th, 2014, MedAssets (NASDAQ:MDAS) reported its earnings. Analysts, on average, expected earnings of $0.31 per share on sales of $172.5 million. MedAssets actually reported earnings of $0.34 per share on sales of $175.7 million, beating EPS estimates by $0.03 and beating revenue estimates by $3.2 million. Shares of MedAssets have slipped from $23.04 to $20.50, representing a loss of 11.0%, since the company reported earnings 19 days ago.
MDAS: 19.39 (-0.35)

Downgrade Alert for MedAssets (MDAS)
Comtex SmarTrend(R) - Mon Nov 17, 8:00AM CST
MedAssets (NASDAQ:MDAS) was downgraded from Outperform to Market Perform at Raymond James today. The stock closed yesterday at $20.50 on volume of 543,000 shares, below average daily volume of 675,000. MedAssets (NASDAQ:MDAS) has potential upside of 20.8% based on a current price of $20.50 and analysts' consensus price target of $24.76. MedAssets shares should first meet resistance at the 50-day moving average (MA) of $21.35 and find additional resistance at the 200-day MA of $22.68.
MDAS: 19.39 (-0.35)

InsiderInsights.com Daily Round Up 11/7/14: AKS, ENH, SCCO, ERII
InsiderInsights - at Seeking Alpha - Sun Nov 09, 1:24AM CST

SCCO: 29.70 (-0.62), WWWW: 16.55 (-0.22), HA: 18.54 (-0.22), ARI: 16.46 (-0.13), BBY: 35.21 (+0.31), AKS: 6.21 (-0.18), BMY: 58.59 (-0.11), CDW: 32.81 (-0.43), HT: 7.22 (-0.10), K: 65.60 (unch), SPW: 92.16 (-0.62), STAA: 8.63 (-0.07), NDLS: 22.46 (-0.19), SIX: 40.28 (-0.52), BAGL: 20.23 (-0.01), MDAS: 19.39 (-0.35), ENH: 57.45 (-0.22), SCHW: 28.37 (-0.39), ERII: 4.86 (-0.04)

MedAssets Beats on Q3 Earnings, Revenues; Both Rise Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 9:55AM CST
MedAssets, Inc. (MDAS) reported adjusted earnings per share (EPS) of 29 cents in the third quarter of 2014, beating the Zacks Consensus Estimate by couple of cents.
BGMD: 0.41 (+0.01), BEAT: 8.28 (-0.19), MDAS: 19.39 (-0.35), ICLR: 53.56 (+0.23)

MedAssets 13th Annual Business and Technology Forum Drives Collaboration and Innovation Among Healthcare Supply Chain Leaders
GlobeNewswire - Fri Nov 07, 9:00AM CST
MedAssets (Nasdaq:MDAS) recently held its 13th annual Business and Technology Forum in Dallas, Texas. The goal of the Business and Technology Forum is to drive industry collaboration and share innovation between healthcare providers and suppliers of quality healthcare products and services. Key event highlights included:
MDAS: 19.39 (-0.35)

MedAssets (MDAS) Crumbles: Stock Falls by 5.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 7:31AM CDT
Make sure to keep a close watch on MedAssets in the near future, and especially on earnings estimates following the recent slump.
MDAS: 19.39 (-0.35)

MedAssets' (MDAS) CEO John Bardis on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Oct 29, 11:06PM CDT

MDAS: 19.39 (-0.35)

MedAssets (MDAS) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Oct 29, 3:55PM CDT

MDAS: 19.39 (-0.35)

MedAssets beats by $0.03, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 3:42PM CDT

MDAS: 19.39 (-0.35)

MedAssets Reports Third Quarter and Nine-Month 2014 Financial Results
GlobeNewswire - Wed Oct 29, 3:11PM CDT
MedAssets, Inc. (Nasdaq:MDAS) today announced results for its third quarter and nine-month period ended September 30, 2014.
MDAS: 19.39 (-0.35)

Stock Futures Down, Off Lows; Leaders Take Early Hits
at Investor's Business Daily - Fri Oct 10, 8:04AM CDT
Stock futures pointed to a lower open Friday, but significantly trimmed their losses about a half hour before the start of trade. Dow futures were 19 points below fair market value. Nasdaq 100 futures were down 21.1 points. S&P 500 futures backed off...
TSLA: 247.49 (-10.21), KN: 19.65 (-0.49), MDAS: 19.39 (-0.35), MBLY: 46.83 (-0.50)

MedAssets to Report Third Quarter and Nine-Month 2014 Financial Results on Wednesday, October 29th After 4:00 p.m. ET
GlobeNewswire - Mon Oct 06, 10:30AM CDT
MedAssets, Inc. (Nasdaq:MDAS) today announced that it plans to release its financial results for the third quarter and nine-month period ended September 30, 2014 after 4:00 p.m. ET on Wednesday, October 29, 2014.
MDAS: 19.39 (-0.35)

AHMC Healthcare Inc., and Alhambra Hospital Medical Center Engage MedAssets for Enhanced Pricing Capabilities to Improve Overall Financial Performance
GlobeNewswire - Thu Oct 02, 9:30AM CDT
MedAssets (Nasdaq:MDAS) today announced that AHMC Healthcare Inc., and Alhambra Hospital and Medical Center has expanded its relationship with the company in pursuit of a rational and defensible pricing strategy. Plans call for a combination of the company's Patient Access Solutions, Contract and Episode Management Solutions and Charge, Pricing and Compliance Solutions to improve the accuracy of patient bill estimation and gain market intelligence to inform payor contract negotiations.
MDAS: 19.39 (-0.35)

MedAssets Closes Sg2 Acquisition for $142M but Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 10:30AM CDT
MedAssets, Inc. (MDAS) expects the Sg2 business to prove slightly accretive in calendar 2015 on a stand-alone basis, and the company may increase its investment to drive additional long-term growth opportunities.
AIRM: 44.82 (-0.04), EVHC: 34.04 (-0.09), MDAS: 19.39 (-0.35), ICLR: 53.56 (+0.23)

MedAssets Completes Acquisition of Sg2
GlobeNewswire - Mon Sep 22, 3:46PM CDT
MedAssets (Nasdaq:MDAS) today announced that it completed its previously announced acquisition of SG-2, LLC (Sg2), a leading provider of healthcare business intelligence, market analytics and clinical consulting services.
MDAS: 19.39 (-0.35)

MedAssets Announces Call for Speakers for 2015 Healthcare Business Summit
GlobeNewswire - Thu Sep 11, 7:30AM CDT
MedAssets today announced the opening for the Call for Speakers for the 2015 Healthcare Business Summit to be held April 7-9, 2015 at the Mandalay Bay Resort & Convention Center in Las Vegas. The annual Summit brings together more than 4,000 industry leaders to address the unprecedented challenges and pursue innovative strategies to improve operational, financial and clinical performance for the evolving business models.
MDAS: 19.39 (-0.35)

Baylor Scott & White Health Chooses MedAssets for Procurement Operations
GlobeNewswire - Mon Sep 08, 9:11AM CDT
MedAssets (Nasdaq:MDAS) today announced that Baylor Scott & White Health, the largest not-for-profit healthcare system in Texas, has moved from its current eCommerce provider to the MedAssets eCommerce Exchange, an integral component of MedAssets Procure-to-Pay Solutions.
MDAS: 19.39 (-0.35)

MedAssets Extends Relationship with LHP Hospitals but Slips - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 12:40PM CDT
Both MedAssets (MDAS) and LHP will work together to implement a unique approach to sustain improvements in financial, operational and clinical performance under the extended agreement.
AIRM: 44.82 (-0.04), Q: 57.50 (+0.17), MDAS: 19.39 (-0.35), ICLR: 53.56 (+0.23)

LHP Hospital Group, Inc. Expands Relationship With MedAssets to Reduce the Total Cost of Care and Align Clinical Delivery Across the Enterprise
GlobeNewswire - Wed Sep 03, 7:30AM CDT
MedAssets (Nasdaq:MDAS) today announced that LHP Hospital Group, Inc. (LHP), a privately held company established to provide essential capital and expertise to not-for-profit hospitals and hospital systems, has elected to renew and expand its relationship with the company. In its advisory services role, MedAssets will deploy a wide array of its total cost management and clinical alignment solutions to streamline processes and improve performance across the 1,333-bed, six-hospital healthcare group, including Supply Chain Solutions, Procure-to-Pay Solutions, Cost Analytics and Operational Improvement Solutions. The new agreement builds upon the existing relationship and the deployment at LHP's hospitals of MedAssets Strategic Sourcing.
MDAS: 19.39 (-0.35)

MedAssets to Participate in the FBR and Baird Investment Conferences on Sept. 3-4, 2014
GlobeNewswire - Fri Aug 29, 8:00AM CDT
MedAssets (Nasdaq:MDAS) today announced that it will participate in two investment conferences during the first week of September.
MDAS: 19.39 (-0.35)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 43

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 0

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 282

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 127

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 12

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 0

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 75

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 141

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 336

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading

Top 5 Most Recently Viewed Articles

Regeneron Faces Class Action Over Tumultuous Trial Results

Updated Category News Views 13

Regeneron's Meltdown: A Bitter Pill for Investors Let’s dive headlong into the mess Regeneron Pharmaceuticals (NASDAQ:REGN) finds itself in—a classic nightmare scenario for investors. News broke like an old valve bursting, and suddenly, the market's love for Regeneron ran ice-cold. Who's to blame this time? Well, you might want to point a finger at the failed Phase 3...

Continue Reading
Avalo Therapeutics Achieves Significant Milestones in 2025

Updated Category News Views 332

Avalo Therapeutics: Progress and Financial Highlights Avalo Therapeutics, Inc. (NASDAQ: AVTX), a dedicated biotechnology company, focuses on developing innovative therapies targeting immune-mediated inflammatory diseases. Recently, Avalo announced significant updates and financial results for the second quarter of 2025, showcasing a robust pipeline and strong financial...

Continue Reading
Splash Beverage Group Shares Surge: Insights on Recent Growth

Updated Category News Views 155

Splash Beverage Group Inc. Sees Major Stock Surge Recently, shares of Splash Beverage Group Inc. (NASDAQ: SBEV) soared by an impressive 40.52% during after-hours trading. The stock reached a price of $1.05, marking a significant rebound from previous lows. Understanding the Price Movement During regular trading hours, SBEV shares had closed at $0.75, reflecting a decrease...

Continue Reading
Streamlining ACA Form Corrections with ez1095 Software

Updated Category News Views 118

Revolutionizing ACA Compliance with ez1095 For current clients using ez1095, navigating the complexities of ACA form corrections has become profoundly easier. Already in use for 2024, the ez1095 software revolutionizes the way clients manage their forms, eliminating the headaches traditionally associated with such tasks. Enhancements and Features of ez1095 The ez1095 team...

Continue Reading
Roth Staffing Companies Celebrates Recognition as Top Workplace

Updated Category News Views 231

Roth Staffing Companies Earns Top Workplace Honor for 2025 Roth Staffing Companies is thrilled to announce that it has received the prestigious Top Workplaces USA award for 2025. This honor, given by a renowned organization, celebrates companies that prioritize a positive work culture and engage their employees effectively. Celebrating Company Culture The Top Workplaces...

Continue Reading